Cardinal Health, Inc. (CAH)

US — Healthcare Sector
Peers: MCK  COR  HSIC  OMI  BDX  BAX  BEN 

Automate Your Wheel Strategy on CAH

With Tiblio's Option Bot, you can configure your own wheel strategy including CAH - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol CAH
  • Rev/Share 931.2887
  • Book/Share -11.0209
  • PB -13.4625
  • Debt/Equity -3.0662
  • CurrentRatio 0.9351
  • ROIC 0.115

 

  • MktCap 37407512767.0
  • FreeCF/Share 7.7406
  • PFCF 20.2203
  • PE 23.9842
  • Debt/Assets 0.1605
  • DivYield 0.013
  • ROE -0.5205

 

  • Rating B-
  • Score 2
  • Recommendation Sell
  • P/E Score 2
  • DCF Score 5
  • P/B Score 1
  • D/E Score 1

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
Upgrade CAH Wells Fargo Equal Weight Overweight -- $179 June 3, 2025
Upgrade CAH Jefferies Hold Buy $140 $150 Feb. 5, 2025
Upgrade CAH TD Cowen Hold Buy $130 $144 Jan. 8, 2025
Upgrade CAH Evercore ISI In-line Outperform -- $140 Jan. 7, 2025
Upgrade CAH BofA Securities Neutral Buy $132 $145 Jan. 6, 2025
Upgrade CAH Wells Fargo Underweight Equal Weight $101 $127 Dec. 13, 2024
Resumed CAH Mizuho -- Outperform -- $139 Dec. 4, 2024

News

Should You Continue to Hold Bio-Techne Stock in Your Portfolio?
CAH, MASI, PAHC, TECH
Published: October 08, 2025 by: Zacks Investment Research
Sentiment: Neutral

TECH drives growth via acquisitions, international strength and innovation. However, it faces macro pressures and rising competition.

Read More
image for news Should You Continue to Hold Bio-Techne Stock in Your Portfolio?
CAH Expands Distribution Network With Indianapolis Facility
CAH
Published: October 07, 2025 by: Zacks Investment Research
Sentiment: Positive

Cardinal Health accelerates its multi-year supply chain transformation with a new flagship Indianapolis distribution center, reinforcing automation-driven efficiency while building on recent logistics expansions in Ohio and Texas.

Read More
image for news CAH Expands Distribution Network With Indianapolis Facility
Is Cardinal Health (CAH) Stock Undervalued Right Now?
CAH
Published: October 06, 2025 by: Zacks Investment Research
Sentiment: Positive

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Read More
image for news Is Cardinal Health (CAH) Stock Undervalued Right Now?
Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term
CAH
Published: October 03, 2025 by: Zacks Investment Research
Sentiment: Positive

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Read More
image for news Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term
Cardinal Health to Build Indianapolis Pharma Plant to Supply Growing Distribution
CAH
Published: September 30, 2025 by: WSJ
Sentiment: Positive

The planned 230,000 square-foot plant is the healthcare company's latest step in a 10-year plan to modernize and expand its distribution network.

Read More
image for news Cardinal Health to Build Indianapolis Pharma Plant to Supply Growing Distribution
Cardinal Health to expand pharmaceutical distribution network with new Indianapolis facility
CAH
Published: September 30, 2025 by: PRNewsWire
Sentiment: Neutral

DUBLIN, Ohio , Sept. 30, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced plans for a new flagship forward distribution center in Indianapolis, Indiana that will further expand and modernize its national pharmaceutical distribution network.

Read More
image for news Cardinal Health to expand pharmaceutical distribution network with new Indianapolis facility
Cardinal (CAH) Upgraded to Buy: Here's What You Should Know
CAH
Published: September 26, 2025 by: Zacks Investment Research
Sentiment: Positive

Cardinal (CAH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Read More
image for news Cardinal (CAH) Upgraded to Buy: Here's What You Should Know
Why Cardinal Health (CAH) is a Top Growth Stock for the Long-Term
CAH
Published: September 26, 2025 by: Zacks Investment Research
Sentiment: Positive

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Read More
image for news Why Cardinal Health (CAH) is a Top Growth Stock for the Long-Term
Cardinal Health, Inc. (CAH) Presents at Bank of America Global Healthcare Conference 2025 Transcript
CAH
Published: September 24, 2025 by: Seeking Alpha
Sentiment: Neutral

Cardinal Health, Inc. (NYSE:CAH ) Bank of America Global Healthcare Conference 2025 September 24, 2025 11:10 AM EDT Company Participants Matt Sims - Vice President of Investor Relations Jason Hollar - CEO & Director Aaron Alt - Chief Financial Officer Conference Call Participants Allen Lutz - BofA Securities, Research Division Presentation Allen Lutz BofA Securities, Research Division All right. Good morning, everyone.

Read More
image for news Cardinal Health, Inc. (CAH) Presents at Bank of America Global Healthcare Conference 2025 Transcript
Should Value Investors Buy Cardinal Health (CAH) Stock?
CAH
Published: September 19, 2025 by: Zacks Investment Research
Sentiment: Positive

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Read More
image for news Should Value Investors Buy Cardinal Health (CAH) Stock?
Here's Why Cardinal Health (CAH) is a Strong Value Stock
CAH
Published: September 17, 2025 by: Zacks Investment Research
Sentiment: Positive

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Read More
image for news Here's Why Cardinal Health (CAH) is a Strong Value Stock
CAH Strengthens Distribution With New Consumer Health Logistics Hub
CAH
Published: September 17, 2025 by: Zacks Investment Research
Sentiment: Positive

Cardinal Health opens a 350,000-square-foot Consumer Health Logistics Center in Ohio, strengthening its pharmaceutical supply chain and advancing its multiyear infrastructure expansion strategy.

Read More
image for news CAH Strengthens Distribution With New Consumer Health Logistics Hub
Cardinal Health Unveils State-of-the-Art Consumer Health Logistics Center
CAH
Published: September 15, 2025 by: PRNewsWire
Sentiment: Neutral

DUBLIN, Ohio , Sept. 15, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today is showcasing its newly operational Consumer Health Logistics Center, a 350,000-square-foot facility in Groveport, Ohio.

Read More
image for news Cardinal Health Unveils State-of-the-Art Consumer Health Logistics Center
Cardinal Health, Inc. (CAH) Presents At Baird Global Healthcare Conference 2025 Transcript
CAH
Published: September 10, 2025 by: Seeking Alpha
Sentiment: Neutral

Cardinal Health, Inc. (NYSE:CAH ) Baird Global Healthcare Conference 2025 September 10, 2025 8:30 AM EDT Company Participants Matt Sims - Vice President of Investor Relations Jason Hollar - CEO & Director Aaron Alt - Chief Financial Officer Conference Call Participants Eric Coldwell - Robert W. Baird & Co. Incorporated, Research Division Presentation Eric Coldwell Senior Research Analyst Good to go.

Read More
image for news Cardinal Health, Inc. (CAH) Presents At Baird Global Healthcare Conference 2025 Transcript
Is Cardinal Health (CAH) Stock Outpacing Its Medical Peers This Year?
CAH
Published: September 10, 2025 by: Zacks Investment Research
Sentiment: Positive

Here is how Cardinal Health (CAH) and Adaptive Biotechnologies (ADPT) have performed compared to their sector so far this year.

Read More
image for news Is Cardinal Health (CAH) Stock Outpacing Its Medical Peers This Year?
Cardinal Health Expands At-Home Solutions With New Texas Facility
CAH
Published: September 08, 2025 by: Zacks Investment Research
Sentiment: Positive

CAH announces the opening of a new distribution center in Texas, which is likely to support its at-Home Solutions business.

Read More
image for news Cardinal Health Expands At-Home Solutions With New Texas Facility
Cardinal Health, Inc. (CAH) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 (Transcript)
CAH
Published: September 04, 2025 by: Seeking Alpha
Sentiment: Neutral

Cardinal Health, Inc. (NYSE:CAH ) Wells Fargo 20th Annual Healthcare Conference 2025 September 4, 2025 11:00 AM EDT Company Participants Matt Sims - Vice President of Investor Relations Jason Hollar - CEO & Director Conference Call Participants Stephen Baxter - Wells Fargo Securities, LLC, Research Division Presentation Stephen Baxter Senior Equity Analyst Well, good morning. Steve Baxter, the health care services analyst here at Wells Fargo.

Read More
image for news Cardinal Health, Inc. (CAH) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 (Transcript)
Cardinal Health at-Home Solutions opens Texas distribution center; announces plans for new California site
CAH
Published: September 04, 2025 by: PRNewsWire
Sentiment: Neutral

DUBLIN, Ohio , Sept. 4, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced the opening of its newest distribution center in Fort Worth, Texas – a facility solely dedicated to the at-Home Solutions business, a leading medical supplies provider that serves more than 6 million people annually in the United States.

Read More
image for news Cardinal Health at-Home Solutions opens Texas distribution center; announces plans for new California site
Is Cardinal (CAH) a Solid Growth Stock? 3 Reasons to Think "Yes"
CAH
Published: September 03, 2025 by: Zacks Investment Research
Sentiment: Positive

Cardinal (CAH) could produce exceptional returns because of its solid growth attributes.

Read More
image for news Is Cardinal (CAH) a Solid Growth Stock? 3 Reasons to Think "Yes"
Should Value Investors Buy Cardinal Health (CAH) Stock?
CAH
Published: September 03, 2025 by: Zacks Investment Research
Sentiment: Positive

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Read More
image for news Should Value Investors Buy Cardinal Health (CAH) Stock?
Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term
CAH
Published: August 29, 2025 by: Zacks Investment Research
Sentiment: Positive

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Read More
image for news Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term
Best Dividend Aristocrats For September 2025
ABBV, ABT, ADM, ADP, AFL, ALB, AMCR, AOS, APD, ATO, BDX, BEN, BRO, CAH, CAT, CB, CHD, CHRW, CINF, CL, CLX, CTAS, CVX, DOV, ECL
Published: August 27, 2025 by: Seeking Alpha
Sentiment: Positive

Dividend Aristocrats have shown mixed 2025 performance, with some delivering double-digit gains and others lagging, but overall stability remains a hallmark. Dividend growth is robust, with 53 of 69 Aristocrats raising payouts in 2025 and an average growth rate of 5.14%, signaling continued income reliability. My 'Promising Aristocrats' list, focused on undervaluation and projected total return, has outperformed both NOBL and SPY in August.

Read More
image for news Best Dividend Aristocrats For September 2025
5 Dividend Growth Stocks to Boost Your Portfolio
AGCO, CAH, TEL, VRT, WWD
Published: August 19, 2025 by: Zacks Investment Research
Sentiment: Positive

Five dividend growth stocks, AGCO, VRT, TEL, CAH and WWD, stand out for their steady payouts, strong fundamentals and long-term upside potential.

Read More
image for news 5 Dividend Growth Stocks to Boost Your Portfolio
Cardinal (CAH) is an Incredible Growth Stock: 3 Reasons Why
CAH
Published: August 18, 2025 by: Zacks Investment Research
Sentiment: Positive

Cardinal (CAH) possesses solid growth attributes, which could help it handily outperform the market.

Read More
image for news Cardinal (CAH) is an Incredible Growth Stock: 3 Reasons Why
All You Need to Know About Cardinal (CAH) Rating Upgrade to Buy
CAH
Published: August 18, 2025 by: Zacks Investment Research
Sentiment: Positive

Cardinal (CAH) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Read More
image for news All You Need to Know About Cardinal (CAH) Rating Upgrade to Buy
Should Value Investors Buy Cardinal Health (CAH) Stock?
CAH
Published: August 18, 2025 by: Zacks Investment Research
Sentiment: Positive

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Read More
image for news Should Value Investors Buy Cardinal Health (CAH) Stock?
Cardinal Health Board of Directors Approves Quarterly Dividend
CAH
Published: August 15, 2025 by: PRNewsWire
Sentiment: Neutral

DUBLIN, Ohio , Aug. 15, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved its quarterly dividend of $0.5107 per share, out of the Company's capital surplus. The dividend will be payable on October 15, 2025 to shareholders of record at the close of business on October 1, 2025.

Read More
image for news Cardinal Health Board of Directors Approves Quarterly Dividend
Cardinal Health to Acquire Solaris Health for Urology Expansion
CAH
Published: August 15, 2025 by: Zacks Investment Research
Sentiment: Positive

CAH is set to buy Solaris Health for $2.4B, boosting urology presence with 750+ providers and expanding Specialty Alliance reach.

Read More
image for news Cardinal Health to Acquire Solaris Health for Urology Expansion
After Plunging 9.1% in 4 Weeks, Here's Why the Trend Might Reverse for Cardinal (CAH)
CAH
Published: August 13, 2025 by: Zacks Investment Research
Sentiment: Negative

The heavy selling pressure might have exhausted for Cardinal (CAH) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

Read More
image for news After Plunging 9.1% in 4 Weeks, Here's Why the Trend Might Reverse for Cardinal (CAH)
Brokers Suggest Investing in Cardinal (CAH): Read This Before Placing a Bet
CAH
Published: August 13, 2025 by: Zacks Investment Research
Sentiment: Negative

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

Read More
image for news Brokers Suggest Investing in Cardinal (CAH): Read This Before Placing a Bet

About Cardinal Health, Inc. (CAH)

  • IPO Date 1983-08-04
  • Website https://www.cardinalhealth.com
  • Industry Medical - Distribution
  • CEO Jason M. Hollar
  • Employees 47922

Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.